SavedAdd your journal

Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2014 / Cilt: 24 - Sayı: 2

WALDENSTROM CASE DEVELOPED SECONDARY TO CHEMOTHERAPY

KEMOTERAPİYE BAĞLI GELİŞEN WALDENSTRÖM OLGUSU

Mehmet Can UĞUR
Ferhat EKİNCİ
Utku Erdem SOYALTIN
Fatma ÖZKAN
İsmail ATASOY
Cengiz CEYLAN
HARUN AKAR
Pages
131–133
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, we must care patients who received chemotherapy for secondary maliginities

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It aimed to analysis and discuss with a case Waldenstrom macroglobulinemmia developed after vincristin-cyclophosphamide therapy.
📊
Key Findings & Data:In this case, we present a patient who developed Waldenstrom macroglobulinemmia after vincristinecyclophosphamide therapy for non-Hodgkin's lymphoma.
💡
Conclusion & Impact:Finally, we must care patients who received chemotherapy for secondary maliginities
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It aimed to analysis and discuss with a case Waldenstrom macroglobulinemmia developed after vincristin-cyclophosphamide therapy. In this case, we present a patient who developed Waldenstrom macroglobulinemmia after vincristinecyclophosphamide therapy for non-Hodgkin's lymphoma. We determine severe thrombocytopenia at the control visit and suspected myelodisplastic syndrome or aplastik anemia primarily. But when we analysed him we diagnosed waldenstrom macroglobulinemia. Finally, we must care patients who received chemotherapy for secondary maliginities

Özet

Kemoterapiye bağlı gelişen Waldenström Makroglobulinemisi'nin bir olgu üzerinden incelenmesi ve tartışılması amaçlanmıştır. Sunmuş olduğumuz olguda non-Hodgkin lenfoma nedeniyle kullanılan siklofosfamid ve vinkristin tedavisi sonrası Waldenström makroglobulinemisi gelişmiştir. Olguda poliklinik kontrolünde derin trombositopeni saptanması üzerine öncelikle miyelodisplastik sendrom ve aplastik anemi düşünülmüştü. Ancak ayrıntılı incelendiğinde olguda Waldenström Makroglobulinmesi saptandı. Kemoterapi sonrası gelişebilecek ikincil maliniteler açısından dikkatli olunmalı ve bu durum akılda tutulmalıdır

🔖

Cite This Article

UĞUR, M. C., EKİNCİ, F., SOYALTIN, U. E., ÖZKAN, F., ATASOY, İ., CEYLAN, C., AKAR, H. (2014). WALDENSTROM CASE DEVELOPED SECONDARY TO CHEMOTHERAPY. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 24 - Sayı: 2, 131–133. https://ajindex.com/articles/268380

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's macroglobulinemia. Semin Oncol. 2003; 30(2): 110–5
  2. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of the Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008. World Health Organization Classification of Tumours; vol 2
  3. Groves FD, Travis LB, Devesa SS, Ries LA, Fraumeni JF Jr. Waldenström's macroglobulinemia: incidence patterns in the united states, 1988–1994. Cancer. 1998; 82(6):1078–81
  4. Herrinton LJ, Weiss NS. Incidence of Waldenström's macroglobulinemia. Blood. 1993; 82(10):3148–50
  5. Aoki H, Takishita M, Kosaka M, Saito S. Frequent somatic mutations in D and/or JH segments of ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood.1995;85(7):1913–9
  6. Koshiol J, Gridley G, Engels EA, McMaster ML, Landgren O. Chronic immune stimulation and subsequent Waldenström macroglobulinemia. Arch Intern Med. 2008;168(17):1903–9
  7. Said JW, Rettig MR, Heppner K, Vescio RA, Schiller G, Ma HJ, Belson D,et al. Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Blood 1997; 90(11): 4278-82 8. Konoplev S, Medeiros LJ, Bueso-Ramos CE, Jorgensen JL, Lin P. Immunophenotypic profile of lymphoplasmacytic lymphoma/ Waldenström macroglobulinemia. Am J Clin Pathol. 2005;124(3):414–20
  8. Nadia N, Yang DT. Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia. Arch Pathol Lab Med 2013: 137( 4): 580-5
  9. Alper Çelik ve ark. Lenfoma nedeniyle uygulanan radyoterapi sonrası sekonder maligniteler-olgu sunumu, Marmara Med J 2006; 19(2);80-5 11. McEvoy GK.Drug Information. American Society of Health-System. Pharmacists, 2004: 929-52 12. Kaplan HG, Malmgren JA, Atwood M. Leukemia incidence following primary breast carcinoma treatment. Cancer 2004;101(7):1529-36
  10. Briasoulis E, Tzouvara E, Tsiara S, Vartholomatos G, Tsekeris P, Bourantas K. Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature. Breast J 2003;9(3):241-5.